scholarly journals Lifetime end-stage kidney disease risk estimation in living kidney donor candidates remains a challenge

2017 ◽  
Vol 31 (1) ◽  
pp. 118-120 ◽  
Author(s):  
Darren Lee ◽  
John B. Whitlam ◽  
Natasha Cook ◽  
Momena Manzoor ◽  
Geoff Harley ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Disease Risk ◽  
Risk Estimation ◽  
Kidney Donor ◽  
End Stage Kidney Disease ◽  
Living Kidney Donor ◽  
End Stage

scholarly journals Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients

2015 ◽  
Vol 31 (1) ◽  
pp. 80-86 ◽  
Author(s):  
Francesco Pesce ◽  
Mattea Diciolla ◽  
Giulio Binetti ◽  
David Naso ◽  
Vito Claudio Ostuni ◽  
...  
Keyword(s):  
Decision Support ◽  
Kidney Disease ◽  
Clinical Decision Support ◽  
Support System ◽  
Clinical Decision Support System ◽  
Disease Risk ◽  
Risk Estimation ◽  
Clinical Decision ◽  
End Stage Kidney Disease ◽  
End Stage

scholarly journals Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

2010 ◽  
Vol 128 (3) ◽  
pp. 345-350 ◽  
Author(s):  
Shay Tzur ◽  
Saharon Rosset ◽  
Revital Shemer ◽  
Guennady Yudkovsky ◽  
Sara Selig ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Disease Risk ◽  
Missense Mutations ◽  
End Stage Kidney Disease ◽  
Myh9 Gene ◽  
End Stage

Impaired Vitamin D Signaling Is Associated With Frequent Development of Renal Cell Tumor in End-stage Kidney Disease

2020 ◽  
Vol 40 (11) ◽  
pp. 6525-6530
Author(s):  
JANOS DOCS ◽  
DANIEL BANYAI ◽  
TIBOR FLASKO ◽  
ARPAD SZANTO ◽  
GYULA KOVACS
Keyword(s):  
Vitamin D ◽  
Kidney Disease ◽  
Renal Cell ◽  
Cell Tumor ◽  
End Stage Kidney Disease ◽  
Vitamin D Signaling ◽  
End Stage

scholarly journals Cardiopulmonary exercise testing (CPET) in patients with end-stage kidney disease (ESKD): principles, methodology and clinical applications of the optimal tool for exercise tolerance evaluation

2021 ◽  
Author(s):  
Eva Pella ◽  
Afroditi Boutou ◽  
Aristi Boulmpou ◽  
Christodoulos E Papadopoulos ◽  
Aikaterini Papagianni ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Exercise Testing ◽  
Cardiopulmonary Exercise Testing ◽  
Exercise Intolerance ◽  
End Stage Kidney Disease ◽  
Exercise Limitation ◽  
Cardiopulmonary Exercise ◽  
Functional Reserves ◽  
Increased Risk ◽  
End Stage

Abstract Chronic kidney disease (CKD), especially end-stage kidney disease (ESKD), is associated with increased risk for cardiovascular events and all-cause mortality. Exercise intolerance as well as reduced cardiovascular reserve are extremely common in patients with CKD. Cardiopulmonary exercise testing (CPET) is a non-invasive, dynamic technique that provides an integrative evaluation of cardiovascular, pulmonary, neuropsychological and metabolic function during maximal or submaximal exercise, allowing the evaluation of functional reserves of these systems. This assessment is based on the principle that system failure typically occurs when the system is under stress and, thus, CPET is currently considered to be the gold-standard for identifying exercise limitation and differentiating its causes. It has been widely used in several medical fields for risk stratification, clinical evaluation and other applications but its use in everyday practice for CKD patients is scarce. This article describes the basic principles and methodology of CPET and provides an overview of important studies that utilized CPET in patients with ESKD, in an effort to increase awareness of CPET capabilities among practicing nephrologists.

Psychosocial factors affecting patients with end-stage kidney disease and the impact of the social worker

2021 ◽  
Author(s):  
Micaella Sotera Hansen ◽  
Wubshet Tesfaye ◽  
Beena Sewlal ◽  
Bharati Mehta ◽  
Kamal Sud ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Psychosocial Factors ◽  
Social Worker ◽  
End Stage Kidney Disease ◽  
Factors Affecting ◽  
The Social ◽  
End Stage ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document